Novarex Overview

  • Founded
  • 2008

Founded

  • Status
  • Public

  • Employees
  • 412

Employees

  • Stock Symbol
  • 194700

Stock Symbol

  • Share Price
  • $8.15
  • (As of Friday Closing)

Novarex General Information

Description

Novarex Co Ltd offers dietary supplements including Lactomin, Probiotics, Microencapsulation, Health Supplement, Dietary Supplement, Nutrition, Omega-3, Vitamin, among others.

Contact Information

Website
www.novarex.co.kr
Formerly Known As
Health Science Corporation
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Food Products
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Stock Exchange
KRX
Primary Office
  • 94, Gak-ri 1-gil, Ochang-eup
  • Cheongwun-gu
  • Cheongiu-si, Chungcheongbuk-do
  • South Korea
+82 00000000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novarex Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$8.15 $8.24 $5.86 - $9.96 $153M 17.7M 277K $1.05

Novarex Financials Summary

In Thousands,
USD 		TTM 30-Jun-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 112,553 147,312 287,079 301,673
Revenue 204,488 217,995 243,395 188,729
EBITDA 20,737 25,520 32,447 25,831
Net Income 12,880 15,467 23,050 21,297
Total Assets 199,031 214,252 213,974 197,541
Total Debt 22,044 36,599 46,066 50,656
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Novarex Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novarex‘s full profile, request access.

Request a free trial

Novarex Patents

  • 2

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Novarex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11096979-B2 Pharmaceutical composition for preventing or treating liver diseases, containing licorice extract containing glycyrrhizin and liquiritin Active 25-Apr-2016 0000000000 0
US-20190134130-A1 Pharmaceutical composition for preventing or treating liver diseases, containing licorice extract containing glycyrrhizin and liquiritin Active 25-Apr-2016 0000000000

Novarex Executive Team (2)

Name Title Board Seat Contact Info
Sangjoon Lee Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »

Novarex Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial